TAG:
dianon systems
Bill Bonello Sees Opportunities In Diagnostic Services Companies
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: With the clinical laboratory industry now enjoying growing interest by professional investors, THE DARK REPORT traveled to New York City to meet with financial analyst William B. Bonello, of U S Bancorp Piper Jaffray. Bonello co-authored a just-released overview of what he ca…
National Anatomic Pathology Companies Continue to Grow
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
IT’S BOOM TIME IN ONE SEGMENT of the clinical laboratory world. The national anatomic pathology companies are posting record rates of growth and profits. The sustained and strong financial performance at DIANON Systems, Inc. and IMPATH, Inc. has not gone unnoticed…
Predict Steady Decline In Fees For Web-Based Lab Information
By Robert Michel | From the Volume VII No. 12 – August 21, 2000 Issue
EVEN THOUGH WEB-BASED LAB TEST ordering and results reporting is in its infancy, the free market already seems to be driving prices down. Late in 1999, Healtheon/WebMD, Inc. was reportedly signing contracts to provide Web-based information services for fees ranging between 60¢ and …
Professional Management Does Get Results
By R. Lewis Dark | From the Volume VII No. 11 – July 31, 2000 Issue
IF YOU TAKE THE TIME TO STUDY THE FINANCIAL PERFORMANCE of certain public laboratories in 1999 and into 2000, you will be struck by the strong growth and profit numbers. That is contrary to the popular wisdom, which says that the clinical lab industry is in financial doldrums. But the strong financi…
Lab Industry Attracting New Investment Dollars
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Professional investors with access to hundreds of millions of dollars of investment capital are closely scrutinizing the clinical laboratory industry. They are encouraged by the recent financial performance of public laboratory companies. For independent laboratory owners, th…
Qualigen’s POL PSA Test Cleared for Sale by FDA
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Qualigen, Inc. gained FDA approval to sell its FastPack™ System for PSA testing in the United States. Qualigen is one more example of a technology company that expects to shift diagnostic testing out of core laboratories and closer to the patient. Initially Qualigen will se…
“July 31, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
Medical Management Programs, Inc. (MMP) of Southfield, Michigan is the new owner of the TPA (third party administrator) business formerly held by Universal Standard Medical Laboratories. MMP purchased the TPA business involving lab testing and home health services from USML’s Chapt…
Express Scripts, InformInvestor.com, UroCor, Bio-Reference Laboratories
PRESCRIPTION DRUG SPENDING HITS A RECORD INCREASE OF 17.4% IN 1999 Just-released data from Express Scripts, Inc. indicates that spending on prescription drugs increased by a record 17.4% during 1999. This compares to a 9.6% spending increase for drugs in 1998. As most lab e…
Investors Returning To Lab Industry
By R. Lewis Dark | From the Volume VII No. 9 – June 19, 2000 Issue
SOMETHING BIG IS HAPPENING to the clinical laboratory industry and the anatomic pathology profession. For the first time in six or seven years, the investment community is paying close attention to the laboratory industry. This should be a welcome development for commercial lab owners and anatomic …
“June 19, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 9 – June 19, 2000 Issue
At DIANON Systems, Inc., recent growth in revenues and profits may cost the anatomic pathology company its independence. In recent weeks there’s been widespread speculation that DIANON may be involved in some type of acquisition or merger negotiations. At various times, each of the…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized